Out of seven patients diagnosed with EDS, only two out of seven (29%) had a positive genetic test for COL5A1 and COL3A1. The genetic multipanel test also identified eight more subjects as having EDS: three initially classified as MFS, two as LDS, two as NCTD, and one as BHS. This evidence concerns the gene COL5A1 and Ehlers-Danlos syndrome.